IQVIA Infographic Details Applications of COVID-19 RWD

IQVIA is offering an infographic that illustrates the applications of COVID-19 real world data (RWD). Such data can be used in a variety of focus areas, including by epidemiologists, health economics and outcomes researchers, medical affairs professionals, and safety experts.

“While randomized controlled trials (RCTs) are recognized as the gold standard for drug development approvals, it is increasingly evident that other data types, such as secondary and patient-generated data, and data from registries, are delivering additional insights into patient journeys and the burden of disease in the real world. Real world data (RWD) sources present timely and high-quality COVID-19 data beyond RCTs.” Read more here.

(Source: IQVIA, 2021)